HealthMore in Health→
Low-dose cancer therapy study points to access gains
Key Takeaways
- STAT highlighted ultra-low-dose immunotherapy as a potential way to cut treatment costs.
- The candidate frames the development around improved access in poorer countries.
- The broader significance is economic as well as clinical.
DE
DT Editorial Team··via statnews.com